SHORT MINI-FUTURE - BRISTOL-MYERS SQUIBB | Market Closed - Deutsche Boerse AG 11:34:40 27/05/2024 pm IST | ||
| 5.11 EUR | 0.00% |
|
| Current month | +4.50% | ||
| 1 month | +5.80% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BRISTOL-MYERS SQUIBB COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 27/24/27 | 5.11 | 0.00% |
| 24/24/24 | 5.11 | 0.00% |
| 23/24/23 | 5.11 | +1.79% |
| 22/24/22 | 5.02 | 0.00% |
| 21/24/21 | 5.02 | +2.45% |
Delayed Quote Deutsche Boerse AG
Last update May 27, 2024 at 11:34 pm IST
More quotesStatic data
| Product type | Knock-Out con Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | BRISTOL-MYERS SQUIBB COMPANY |
| Issuer | 
Vontobel
|
| WKN | VV9EYB |
| ISIN | DE000VV9EYB8 |
| Date issued | 09/11/2022 |
| Strike | 96.98 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 1.91 € |
| Emission volume | N/A |
| Settlement | Por diferencias |
| Currency | EUR |
Technical Indicators
| Highest since issue | 5.15 € |
|---|---|
| Lowest since issue | 1.63 € |
Company Profile
Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques.
The United States account for 70.1% of net sales.
Sector
-
Ratings for Bristol-Myers Squibb Company
Trading Rating
Investor Rating
ESG Refinitiv
B
Consensus: Bristol-Myers Squibb Company
Sell
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
41.24
USD
Average target price
53.19
USD
Spread / Average Target
+28.99%
- Stock Market
- Certificates
- Certificat
